Inventory increased 168.2%
Inventory changed +168.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory changed +168.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Net income changed +228.8% from the comparable as-filed period.
Operating income changed +526.2% from the comparable as-filed period.
Operating margin changed +6087 basis points from the comparable as-filed period.
Revenue changed +101.5% from the comparable as-filed period.
Stock-based compensation changed +25.6% from the comparable as-filed period.
Research & development changed -12.2% from the comparable as-filed period.
Selling, general & administrative changed -5.4% from the comparable as-filed period.
Cash & equivalents changed +3.2% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.